Prof. Dr. Peter Goebell



Organisationseinheit


Urologische Klinik
Medizinische Fakultät


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 8 Go to next page Go to last page

Schmidkonz, C., Cordes, M., Goetz, T.I., Prante, O., Kuwert, T., Ritt, P.,... Bäuerle, T. (2019). 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients. Annals of Nuclear Medicine. https://dx.doi.org/10.1007/s12149-019-01387-0
Black, P.C., Goebell, P., Kamat, A.M., Nawroth, R., Seiler, R., Williams, S.B., & Schmitz-Dräger, B.J. (2019). Editorial: Basic research in bladder cancer – refining the tools. 3rd IBCN seminars series1. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2019.01.003
Seiler, R., Black, P.C., Williams, S.B., Goebell, P., Kamat, A.M., Nawroth, R., & Schmitz-Dräger, B.J. (2019). Editorial: Bladder cancer within the focus of basic and clinical research. Sixth IBCN Seminars Series. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2019.06.025
Wülfing, C., Bögemann, M., Goebell, P., Hammerer, P., Machtens, S., Pfister, D.,... Schostak, M. (2019). Erratum zu: Therapiesituation beim metastasierten kastrationsnaiven Prostatakarzinom (mCNPC) und die Auswirkungen im klinischen Alltag (Der Urologe, (2019), 10.1007/s00120-019-0925-2). Urologe. https://dx.doi.org/10.1007/s00120-019-0985-3
Kahlmeyer, A., Stoehr, C.G., Hartmann, A., Goebell, P., Wullich, B., Wach, S.,... Erlmeier, F. (2019). Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma. Journal of Clinical Medicine, 8(5). https://dx.doi.org/10.3390/jcm8050743
Goebell, P., Hermann, E., Kube, U., Doehn, C., Marschner, N., Dietel, A.,... Bergmann, L. (2019). Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study. Oncology Research and Treatment, 42(1-2), 57-66. https://dx.doi.org/10.1159/000494278
Krege, S., & Goebell, P. (2019). Leitlinienadhärenz. Urologe, 58(9), 1016-1018. https://dx.doi.org/10.1007/s00120-019-0994-2
Grünwald, V., Doehn, C., & Goebell, P. (2019). Molecular tumor board—renal cell carcinoma Molekulares Tumorboard – Nierenzellkarzinom. Urologe. https://dx.doi.org/10.1007/s00120-019-0965-7
Boormans, J.L., Zwarthoff, E.C., Black, P.C., Goebell, P., Kamat, A.M., Nawroth, R.,... Schmitz-Dräger, B.J. (2019). New horizons in bladder cancer research. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2018.12.014
Kahlmeyer, A., Goebell, P., & Wullich, B. (2019). Presurgical assessments (Assessments vor Operationen). Urologe, 58(4), 373-380. https://dx.doi.org/10.1007/s00120-019-0888-3

Zuletzt aktualisiert 2019-26-03 um 22:51